This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Valorisation-Recherche, Limited Partnership, Micronics, Inc., Université Paul Sabatier (Toulouse III). Active years: 1999-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Montréal, CA (2002)
- Montreal, CA (1999 - 2018)
Company Filing History:
2 out of 43 
1 out of 48 
1 out of 162 
Years Active: 1999-2018
Title: Jurgen Sygusch: Innovator in Biomedicine
Introduction
Jurgen Sygusch is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of biomedicine, particularly in the development of novel therapeutic compounds and peptides. With a total of 4 patents, his work has the potential to impact cancer treatment and immunization strategies.
Latest Patents
One of Sygusch's latest patents is titled "Antigenic epitopes from EBV gp350/220 and uses thereof." This invention relates to a peptide that comprises specific amino acid sequences designed to bind to monoclonal antibodies. The peptide may be useful for inducing the production of neutralizing antibodies against herpesviruses, such as Epstein-Barr virus (EBV). Another significant patent is for "Aldolase-inhibiting aromatic compounds." This invention focuses on novel compounds that inhibit aldolase, which can be used as medicaments for treating certain cancers due to their efficacy in inhibition.
Career Highlights
Throughout his career, Jurgen Sygusch has worked with various organizations, including Valorisation-Recherche, Limited Partnership and Micronics, Inc. His innovative work has positioned him as a key figure in the biomedicine sector.
Collaborations
Sygusch has collaborated with notable individuals such as Casimir Blonski and Mathieu Coinçon. These partnerships have likely contributed to the advancement of his research and inventions.
Conclusion
Jurgen Sygusch's contributions to biomedicine through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and immunization.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile